insights_auto
Why is MNKD down 2.88%?
Dive Deeperchevron_right
MNKD:NASDAQ
MannKind Corp
$3.71
arrow_downward
-2.88%(-0.11) 1D
$3.66
arrow_downward
-1.35% (-0.050)todayPre-market
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$3.86
High
$3.86
Low
$3.69
Mkt. cap
1.19B
Avg. vol.
4.35M
Volume
14.00K
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.09
Shares outstanding
321.54M
No. of employees
592
Open
$3.86
High
$3.86
Low
$3.69
Mkt. cap
1.19B
Avg. vol.
4.35M
Volume
14.00K
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.09
Shares outstanding
321.54M
No. of employees
592
News stories
From web sources and news partners
AD HOC NEWS
·
2 days ago
MannKind stock fell 3.8 percent as analysts kept a positive view
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorBiotechnology
Websitemannkindcorp.com